Literature DB >> 11729215

Immunohistochemical analysis of E-cadherin, alpha-catenin, beta-catenin, gamma-catenin, and neural cell adhesion molecule (NCAM) in chordoma.

T Naka1, Y Oda, Y Iwamoto, N Shinohara, H Chuman, M Fukui, M Tsuneyoshi.   

Abstract

AIMS: The epithelioid features seen in chordoma are unique among mesenchymal tumours. However, no detailed analysis regarding cell-cell communication has been conducted in this epithelioid tumour. The aims of this study were to investigate cell-cell communication in chordoma.
METHODS: By means of immunohistochemical techniques that incorporated a panel of monoclonal antibodies against cell adhesion molecules (CAMs), including E-cadherin, alpha-catenin, beta-catenin, gamma-catenin, and neural cell adhesion molecule (NCAM), the expression of CAMs was studied in 15 specimens of chordoma and eight specimens of chondrosarcoma.
RESULTS: Most chordoma specimens showed some positive immunoreactivity for all the CAMs examined. For the various CAMs investigated, between two and five cases showed diffuse immunoreactions, indicating well preserved expression. Well preserved expression of all the CAMs examined was limited to only one case, thus indicating that the expression of CAMs was decreased in most of the chordoma specimens; however, no significant correlation was found between the decreased expression of CAMs and the histological grade of malignancy, cellular growth pattern, or clinical parameters in chordoma. In chondrosarcoma, only a few specimens showed positive immunoreactivity for CAMs and the expression of E-cadherin, beta-catenin, gamma-catenin, and NCAM was seen more frequently in the chordoma specimens than in the chondrosarcoma specimens.
CONCLUSIONS: These results suggest that the expression of CAMs is associated with the formation and maintenance of chordoma tissue architecture, just as it is in other epithelial tumours or normal tissue. Immunohistochemistry for CAMs was found to be of diagnostic value for discriminating chordoma from chondrosarcoma, and these markers could be used along with the cytokeratins, which are already used for this purpose.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11729215      PMCID: PMC1731331          DOI: 10.1136/jcp.54.12.945

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  48 in total

1.  E-cadherin expression in squamous cell carcinomas of head and neck: inverse correlation with tumor dedifferentiation and lymph node metastasis.

Authors:  J H Schipper; U H Frixen; J Behrens; A Unger; K Jahnke; W Birchmeier
Journal:  Cancer Res       Date:  1991-12-01       Impact factor: 12.701

2.  Transmembrane control of cadherin-mediated cell adhesion: a 94 kDa protein functionally associated with a specific region of the cytoplasmic domain of E-cadherin.

Authors:  A Nagafuchi; M Takeichi
Journal:  Cell Regul       Date:  1989-11

3.  Immunohistochemical localization of cell adhesion molecule epithelial cadherin in human arachnoid villi and meningiomas.

Authors:  Y Tohma; T Yamashima; J Yamashita
Journal:  Cancer Res       Date:  1992-04-01       Impact factor: 12.701

4.  Expression of E-cadherin in normal, benign, and malignant tissues of female genital organs.

Authors:  M Inoue; H Ogawa; M Miyata; H Shiozaki; O Tanizawa
Journal:  Am J Clin Pathol       Date:  1992-07       Impact factor: 2.493

5.  Cadherin dysfunction in a human cancer cell line: possible involvement of loss of alpha-catenin expression in reduced cell-cell adhesiveness.

Authors:  Y Shimoyama; A Nagafuchi; S Fujita; M Gotoh; M Takeichi; S Tsukita; S Hirohashi
Journal:  Cancer Res       Date:  1992-10-15       Impact factor: 12.701

6.  Cadherin intercellular adhesion molecule in hepatocellular carcinomas: loss of E-cadherin expression in an undifferentiated carcinoma.

Authors:  Y Shimoyama; S Hirohashi
Journal:  Cancer Lett       Date:  1991-05-01       Impact factor: 8.679

7.  Neural cell adhesion molecule expression, neuroendocrine differentiation and prognosis in lung carcinoma.

Authors:  R E Kibbelaar; K E Moolenaar; R J Michalides; P C Van Bodegom; R G Vanderschueren; S S Wagenaar; K P Dingemans; D Bitter-Suermann; O Dalesio; N Van Zandwijk
Journal:  Eur J Cancer       Date:  1991       Impact factor: 9.162

8.  Immunohistochemical evaluation of E-cadherin adhesion molecule expression in human gastric cancer.

Authors:  H Oka; H Shiozaki; K Kobayashi; H Tahara; S Tamura; M Miyata; Y Doki; K Iihara; N Matsuyoshi; S Hirano
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

9.  Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer.

Authors:  R Umbas; J A Schalken; T W Aalders; B S Carter; H F Karthaus; H E Schaafsma; F M Debruyne; W B Isaacs
Journal:  Cancer Res       Date:  1992-09-15       Impact factor: 12.701

10.  Alterations in the expression of uvomorulin and Na+,K(+)-adenosine triphosphatase during mouse skin tumor progression.

Authors:  B Ruggeri; J Caamano; T J Slaga; C J Conti; W J Nelson; A J Klein-Szanto
Journal:  Am J Pathol       Date:  1992-05       Impact factor: 4.307

View more
  6 in total

Review 1.  Current therapeutic options and novel molecular markers in skull base chordomas.

Authors:  Filippo Gagliardi; Nicola Boari; Paola Riva; Pietro Mortini
Journal:  Neurosurg Rev       Date:  2011-10-18       Impact factor: 3.042

2.  UM-Chor1: establishment and characterization of the first validated clival chordoma cell line.

Authors:  John Henry Owen; Christine M Komarck; Anthony C Wang; Waleed M Abuzeid; Richard F Keep; Erin L McKean; Stephen Sullivan; Xing Fan; Mark E P Prince
Journal:  J Neurosurg       Date:  2017-04-21       Impact factor: 5.115

3.  Update on the cytogenetics and molecular genetics of chordoma.

Authors:  Lidia Larizza; Pietro Mortini; Paola Riva
Journal:  Hered Cancer Clin Pract       Date:  2005-02-15       Impact factor: 2.857

Review 4.  The molecular aspects of chordoma.

Authors:  Sukru Gulluoglu; Ozlem Turksoy; Aysegul Kuskucu; Ugur Ture; Omer Faruk Bayrak
Journal:  Neurosurg Rev       Date:  2015-09-12       Impact factor: 3.042

Review 5.  Bench to bedside and back again: molecular mechanisms of alpha-catenin function and roles in tumorigenesis.

Authors:  Jacqueline M Benjamin; W James Nelson
Journal:  Semin Cancer Biol       Date:  2007-09-04       Impact factor: 15.707

6.  α-methylacyl-CoA racemase (AMACR) expression in chordomas differentiates them from chondrosarcomas.

Authors:  Sarit Aviel-Ronen; Oranit Zadok; Aya Vituri; Dvora Nass; Ignat Schwartz; Camila Avivi; Iris Barshack
Journal:  Sci Rep       Date:  2016-02-18       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.